Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.34B 1.16B 1.08B 994M 1.87B 128B 1.9B 12.71B 4.99B 64B 5.04B 4.93B 212B P/E 2026 *
27x
P/E 2027 * 13.9x
Enterprise Value 2.83B 2.45B 2.29B 2.1B 3.95B 269B 4.01B 26.83B 10.53B 135B 10.63B 10.4B 446B EV / Sales 2026 *
1.69x
EV / Sales 2027 * 1.52x
Free-Float
72.35%
Yield 2026 *
-
Yield 2027 * -
1 day+0.88%
1 week+3.60%
Current month+3.60%
1 month-1.20%
3 months+27.21%
6 months+53.20%
Current year+38.89%
1 week 16.99
Extreme 16.99
18.34
1 month 16.04
Extreme 16.04
20.49
Current year 8.7
Extreme 8.7
20.49
1 year 8.7
Extreme 8.7
20.49
3 years 8.7
Extreme 8.7
45.42
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Chairman 64 03/01/2012
Director/Board Member 81 01/01/1992
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap.
3/7/26 Tax

Chief Financial Officer

-5,226 0.0067%
1/7/26 Free

Executive/Senior Manager

5,590 0.0072%
1/7/26 Free

Executive/Senior Manager

11,180 0.0144%
Change 5-day change 1-year change 3-year change Capi.($)
+0.88%+3.60%+36.58%-62.03% 1.34B
-0.14%+2.00%-18.36%-0.59% 187B
+1.44%+2.07%-4.47%+2.88% 112B
-1.40%+2.93%+15.11%+71.75% 61.15B
+0.65%+3.91%+37.08%+53.44% 54.39B
-0.12%+6.79%-5.77%-35.74% 48.17B
+2.08%+1.56%+10.93%-29.94% 31.98B
+2.09%-10.31% - - 30.91B
+1.57%+3.85%+47.20%-6.50% 24.92B
+2.45%+3.97%+0.52%+4.99% 23.14B
Average +0.95%+1.29%+13.20%-0.19% 57.41B
Weighted average by Cap. +0.53%+2.01%+0.60%+8.65%

Financials

2026 *2027 *
Net sales 1.67B 1.45B 1.35B 1.24B 2.33B 159B 2.37B 15.87B 6.23B 79.87B 6.29B 6.15B 264B 1.73B 1.49B 1.4B 1.28B 2.41B 164B 2.45B 16.38B 6.43B 82.43B 6.49B 6.35B 273B
Net income 42.03M 36.36M 33.95M 31.15M 58.58M 4B 59.51M 398M 156M 2.01B 158M 154M 6.63B 78.69M 68.07M 63.57M 58.31M 110M 7.49B 111M 746M 293M 3.75B 296M 289M 12.41B
Net Debt 1.49B 1.29B 1.2B 1.1B 2.08B 142B 2.11B 14.11B 5.54B 71.04B 5.59B 5.47B 235B 1.28B 1.11B 1.04B 952M 1.79B 122B 1.82B 12.18B 4.78B 61.29B 4.83B 4.72B 203B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
07/08/26 USD 17.25 +0.88% 637,402
06/08/26 USD 17.10 -3.28% 563,143
05/08/26 USD 17.68 -1.23% 606,022
04/08/26 USD 17.90 +0.11% 748,606
03/08/26 USD 17.88 +7.39% 1,278,776
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
17.25USD
Average target price
19.56USD
Spread / Average Target
+13.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock